Natural killer-cell counts are associated with molecular relapse-free survival after imatinib discontinuation in chronic myeloid leukemia: the IMMUNOSTIM study
Work
Year: 2017
Type: article
Abstract: Despite persistence of leukemic stem cells, patients with chronic myeloid leukemia who achieve and maintain deep molecular responses may successfully stop the tyrosine kinase inhibitor imatinib. Howev... more
Source: Haematologica
Institutions Inserm, Hôpital Saint-Louis, Institut Bergonié, Délégation Paris 7, Université Paris Cité +13 more
Cites: 50
Cited by: 129
Related to: 10
FWCI: 11.57
Citation percentile (by year/subfield): 99.99
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Sustainable Development Goal Good health and well-being
Open Access status: gold
APC paid (est): $2,157